Beech Biotech is utilizing cutting-edge biology to develop innovative therapies for preeclampsia and other pregnancy-related issues.
Beech Biotech has raised $500K in total funding. The most recent round was Seed. The last funding was announced in April 2026.
Beech Biotech's investors include Bill & Melinda Gates Foundation, Mission BioCapital, BioInnovation Institute Venture Lab.
Beech Biotech is headquartered in Lausanne, Switzerland.
Beech Biotech is utilizing cutting-edge biology to develop innovative therapies for preeclampsia and other pregnancy-related issues.
Beech Biotech is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Beech Biotech — Funding & Investors." VCBacked, April 2, 2026, https://www.vcbacked.co/company/beech-biotech. Accessed July 31, 2026.
VCBacked. (2026). Beech Biotech — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/beech-biotech
{{cite web |title=Beech Biotech — Funding & Investors |url=https://www.vcbacked.co/company/beech-biotech |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated